They have shown that USP42 was overexpressed in breast cancer tissues and further demonstrated, using in vitro studies, that USP42 overexpression promoted cell invasion and migration, as well as that USP42 silencing led not only to a reduction in proliferation, but also to increased apoptosis, suggesting that this gene may act as an oncogene [22]. The gene discussed is USP42; the disease is breast carcinoma.